Cicala Peter 4
4 · Eterna Therapeutics Inc. · Filed Feb 10, 2025
Insider Transaction Report
Form 4
Cicala Peter
Director
Transactions
- Award
Stock Option (Right to buy)
2025-02-07+51,485→ 51,485 totalExercise: $0.34Exp: 2035-02-07→ Common Stock (51,485 underlying)
Footnotes (1)
- [F1]Subject to continued service, one-third of the shares underlying the stock option will vest on the first anniversary of the grant date, and the remaining shares underlying the stock option will vest in 24 substantially equal monthly installments thereafter.